BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 23892589)

  • 1. c-Rel downregulation affects cell cycle progression of human keratinocytes.
    Lorenz VN; Schön MP; Seitz CS
    J Invest Dermatol; 2014 Feb; 134(2):415-422. PubMed ID: 23892589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The c-Rel subunit of NF-κB is a crucial regulator of phenotype and motility of HaCaT keratinocytes.
    Lorenz VN; Schön MP; Seitz CS
    Arch Dermatol Res; 2015 Aug; 307(6):523-30. PubMed ID: 25842167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of centriole duplication in human epidermis, Bowen's disease, and squamous cell carcinoma.
    Watanuki S; Fujita H; Kouyama K; Amagai M; Kubo A
    J Dermatol Sci; 2018 Jul; 91(1):9-18. PubMed ID: 29615326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. c-Rel in Epidermal Homeostasis: A Spotlight on c-Rel in Cell Cycle Regulation.
    Lorenz VN; Schön MP; Seitz CS
    J Invest Dermatol; 2016 Jun; 136(6):1090-1096. PubMed ID: 27032306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Squamous cell carcinomas and increased apoptosis in skin with inhibited Rel/nuclear factor-kappaB signaling.
    van Hogerlinden M; Rozell BL; Ahrlund-Richter L; Toftgård R
    Cancer Res; 1999 Jul; 59(14):3299-303. PubMed ID: 10416581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement factor H: a biomarker for progression of cutaneous squamous cell carcinoma.
    Riihilä PM; Nissinen LM; Ala-Aho R; Kallajoki M; Grénman R; Meri S; Peltonen S; Peltonen J; Kähäri VM
    J Invest Dermatol; 2014 Feb; 134(2):498-506. PubMed ID: 23938460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential proteomic analysis of actinic keratosis, Bowen's disease and cutaneous squamous cell carcinoma by label-free LC-MS/MS.
    Azimi A; Kaufman KL; Ali M; Arthur J; Kossard S; Fernandez-Penas P
    J Dermatol Sci; 2018 Jul; 91(1):69-78. PubMed ID: 29665991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative aspects of nonmelanoma skin cancer.
    Walder EJ
    Clin Dermatol; 1995; 13(6):569-78. PubMed ID: 8882768
    [No Abstract]   [Full Text] [Related]  

  • 9. The p53 homologue DeltaNp63alpha interacts with the nuclear factor-kappaB pathway to modulate epithelial cell growth.
    King KE; Ponnamperuma RM; Allen C; Lu H; Duggal P; Chen Z; Van Waes C; Weinberg WC
    Cancer Res; 2008 Jul; 68(13):5122-31. PubMed ID: 18593911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-cadherin negatively regulates the proliferation of cutaneous squamous carcinoma cells.
    Mukoyama Y; Zhou S; Miyachi Y; Matsuyoshi N
    J Invest Dermatol; 2005 Apr; 124(4):833-8. PubMed ID: 15816843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative histochemical study of Bowen's disease and actinic keratosis: preserved normal basal cells in Bowen's disease.
    Ishida H; Kumakiri M; Ueda K; Lao LM; Yanagihara M; Asamoto K; Imamura Y; Noriki S; Fukuda M
    Eur J Histochem; 2001; 45(2):177-90. PubMed ID: 11512639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Squamous-cell carcinoma in situ is a fiction!
    Ackerman AB; Mones J
    J Cutan Pathol; 2009 Jan; 36(1):74-5; author reply 76. PubMed ID: 19125737
    [No Abstract]   [Full Text] [Related]  

  • 13. AQP3 small interfering RNA and PLD2 small interfering RNA inhibit the proliferation and promote the apoptosis of squamous cell carcinoma.
    Wang X; Tao C; Yuan C; Ren J; Yang M; Ying H
    Mol Med Rep; 2017 Aug; 16(2):1964-1972. PubMed ID: 28656282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triterpenes promote keratinocyte differentiation in vitro, ex vivo and in vivo: a role for the transient receptor potential canonical (subtype) 6.
    Woelfle U; Laszczyk MN; Kraus M; Leuner K; Kersten A; Simon-Haarhaus B; Scheffler A; Martin SF; Müller WE; Nashan D; Schempp CM
    J Invest Dermatol; 2010 Jan; 130(1):113-23. PubMed ID: 19675576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Actinic keratosis, Bowen's disease, keratoacanthoma and squamous cell carcinoma of the skin].
    Majores M; Bierhoff E
    Pathologe; 2015 Feb; 36(1):16-29. PubMed ID: 25663185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. c-Rel is a cell cycle modulator in human melanoma cells.
    Priebe MK; Dewert N; Amschler K; Erpenbeck L; Heinzerling L; Schön MP; Seitz CS; Lorenz VN
    Exp Dermatol; 2019 Feb; 28(2):121-128. PubMed ID: 30466153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apoptosis and cellular proliferation in human epidermal squamous cell neoplasia.
    Makino T; Tatebe S; Goto A; Mihara M; Ito H
    J Cutan Pathol; 1998 Mar; 25(3):136-42. PubMed ID: 9550311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIPK2 expression in progression of cutaneous epithelial neoplasm.
    Kwon MJ; Min SK; Seo J; Kim DH; Sung CO; Lim MS; Cho J; Park HR
    Int J Dermatol; 2015 Mar; 54(3):347-54. PubMed ID: 25711204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spindle cell squamous cell carcinoma arising in Bowen's disease: Case report and review of the published work.
    Kogame T; Tanimura H; Nakamaru S; Makimura K; Okamoto H; Kiyohara T
    J Dermatol; 2017 Sep; 44(9):1055-1058. PubMed ID: 28370387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erk1/2 MAP kinases are required for epidermal G2/M progression.
    Dumesic PA; Scholl FA; Barragan DI; Khavari PA
    J Cell Biol; 2009 May; 185(3):409-22. PubMed ID: 19414607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.